Global Nosocomial Infection Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Nosocomial Infection Treatment Market Overview

• 1.1 Product Overview and Scope of Nosocomial Infection Treatment
• 1.2 Classification of Nosocomial Infection Treatment by Types
  • 1.2.1 Global Nosocomial Infection Treatment Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Nosocomial Infection Treatment Revenue Market Share by Types in 2018
  • 1.2.3 Antibacterial Treatment
  • 1.2.4 Antiviral Treatment
  • 1.2.5 Antifungal Treatment
• 1.3 Global Nosocomial Infection Treatment Market by Application
  • 1.3.1 Global Nosocomial Infection Treatment Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Ventilator Associated Pneumonia
  • 1.3.3 Urinary Tract Infection
  • 1.3.4 Blood Stream Infection
  • 1.3.5 Surgical Site Infection
  • 1.3.6 Gastrointestinal Infection
  • 1.3.7 MRSA
• 1.4 Global Nosocomial Infection Treatment Market by Regions
  • 1.4.1 Global Nosocomial Infection Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Nosocomial Infection Treatment Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Nosocomial Infection Treatment Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nosocomial Infection Treatment Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Nosocomial Infection Treatment Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nosocomial Infection Treatment Status and Prospect (2014-2024)
• 1.5 Global Market Size of Nosocomial Infection Treatment (2014-2024)

2 Company Profiles

• 2.1 Cepheid
  • 2.1.1 Business Overview
  • 2.1.2 Nosocomial Infection Treatment Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Cepheid Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Getinge Group
  • 2.2.1 Business Overview
  • 2.2.2 Nosocomial Infection Treatment Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Getinge Group Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Belimed
  • 2.3.1 Business Overview
  • 2.3.2 Nosocomial Infection Treatment Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Belimed Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Bayer
  • 2.4.1 Business Overview
  • 2.4.2 Nosocomial Infection Treatment Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Bayer Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Abbott
  • 2.5.1 Business Overview
  • 2.5.2 Nosocomial Infection Treatment Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Abbott Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Becton, Dickinson and Company
  • 2.6.1 Business Overview
  • 2.6.2 Nosocomial Infection Treatment Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Becton, Dickinson and Company Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Merck & Co
  • 2.7.1 Business Overview
  • 2.7.2 Nosocomial Infection Treatment Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Merck & Co Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Cantel
  • 2.8.1 Business Overview
  • 2.8.2 Nosocomial Infection Treatment Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Cantel Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 BioMerieux
  • 2.9.1 Business Overview
  • 2.9.2 Nosocomial Infection Treatment Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 BioMerieux Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Kimberly-Clark Corp.
  • 2.10.1 Business Overview
  • 2.10.2 Nosocomial Infection Treatment Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Kimberly-Clark Corp. Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 BioMérieux
  • 2.11.1 Business Overview
  • 2.11.2 Nosocomial Infection Treatment Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 BioMérieux Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Sterigenics International, Inc.
  • 2.12.1 Business Overview
  • 2.12.2 Nosocomial Infection Treatment Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Sterigenics International, Inc. Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Nordion
  • 2.13.1 Business Overview
  • 2.13.2 Nosocomial Infection Treatment Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Nordion Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Advanced Sterilization Products
  • 2.14.1 Business Overview
  • 2.14.2 Nosocomial Infection Treatment Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Advanced Sterilization Products Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Steris
  • 2.15.1 Business Overview
  • 2.15.2 Nosocomial Infection Treatment Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Steris Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Sakura Seiki
  • 2.16.1 Business Overview
  • 2.16.2 Nosocomial Infection Treatment Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Sakura Seiki Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 Pfizer
  • 2.17.1 Business Overview
  • 2.17.2 Nosocomial Infection Treatment Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 Pfizer Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.18 Halyard Health, Inc.
  • 2.18.1 Business Overview
  • 2.18.2 Nosocomial Infection Treatment Type and Applications
    • 2.18.2.1 Product A
    • 2.18.2.2 Product B
  • 2.18.3 Halyard Health, Inc. Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.19 Johnson & Johnson
  • 2.19.1 Business Overview
  • 2.19.2 Nosocomial Infection Treatment Type and Applications
    • 2.19.2.1 Product A
    • 2.19.2.2 Product B
  • 2.19.3 Johnson & Johnson Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.20 Roche
  • 2.20.1 Business Overview
  • 2.20.2 Nosocomial Infection Treatment Type and Applications
    • 2.20.2.1 Product A
    • 2.20.2.2 Product B
  • 2.20.3 Roche Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.21 Matachana Group
  • 2.21.1 Business Overview
  • 2.21.2 Nosocomial Infection Treatment Type and Applications
    • 2.21.2.1 Product A
    • 2.21.2.2 Product B
  • 2.21.3 Matachana Group Nosocomial Infection Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Nosocomial Infection Treatment Market Competition, by Players

• 3.1 Global Nosocomial Infection Treatment Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Nosocomial Infection Treatment Players Market Share
  • 3.2.2 Top 10 Nosocomial Infection Treatment Players Market Share
• 3.3 Market Competition Trend

4 Global Nosocomial Infection Treatment Market Size by Regions

• 4.1 Global Nosocomial Infection Treatment Revenue and Market Share by Regions
• 4.2 North America Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 4.3 Europe Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 4.5 South America Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)

5 North America Nosocomial Infection Treatment Revenue by Countries

• 5.1 North America Nosocomial Infection Treatment Revenue by Countries (2014-2019)
• 5.2 USA Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 5.3 Canada Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)

6 Europe Nosocomial Infection Treatment Revenue by Countries

• 6.1 Europe Nosocomial Infection Treatment Revenue by Countries (2014-2019)
• 6.2 Germany Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 6.3 UK Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 6.4 France Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 6.5 Russia Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 6.6 Italy Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Nosocomial Infection Treatment Revenue by Countries

• 7.1 Asia-Pacific Nosocomial Infection Treatment Revenue by Countries (2014-2019)
• 7.2 China Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 7.3 Japan Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 7.4 Korea Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 7.5 India Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)

8 South America Nosocomial Infection Treatment Revenue by Countries

• 8.1 South America Nosocomial Infection Treatment Revenue by Countries (2014-2019)
• 8.2 Brazil Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Nosocomial Infection Treatment by Countries

• 9.1 Middle East and Africa Nosocomial Infection Treatment Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 9.3 UAE Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Nosocomial Infection Treatment Revenue and Growth Rate (2014-2019)

10 Global Nosocomial Infection Treatment Market Segment by Type

• 10.1 Global Nosocomial Infection Treatment Revenue and Market Share by Type (2014-2019)
• 10.2 Global Nosocomial Infection Treatment Market Forecast by Type (2019-2024)
• 10.3 Antibacterial Treatment Revenue Growth Rate (2014-2024)
• 10.4 Antiviral Treatment Revenue Growth Rate (2014-2024)
• 10.5 Antifungal Treatment Revenue Growth Rate (2014-2024)

11 Global Nosocomial Infection Treatment Market Segment by Application

• 11.1 Global Nosocomial Infection Treatment Revenue Market Share by Application (2014-2019)
• 11.2 Nosocomial Infection Treatment Market Forecast by Application (2019-2024)
• 11.3 Ventilator Associated Pneumonia Revenue Growth (2014-2019)
• 11.4 Urinary Tract Infection Revenue Growth (2014-2019)
• 11.5 Blood Stream Infection Revenue Growth (2014-2019)
• 11.6 Surgical Site Infection Revenue Growth (2014-2019)
• 11.7 Gastrointestinal Infection Revenue Growth (2014-2019)
• 11.8 MRSA Revenue Growth (2014-2019)

12 Global Nosocomial Infection Treatment Market Size Forecast (2019-2024)

• 12.1 Global Nosocomial Infection Treatment Market Size Forecast (2019-2024)
• 12.2 Global Nosocomial Infection Treatment Market Forecast by Regions (2019-2024)
• 12.3 North America Nosocomial Infection Treatment Revenue Market Forecast (2019-2024)
• 12.4 Europe Nosocomial Infection Treatment Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Nosocomial Infection Treatment Revenue Market Forecast (2019-2024)
• 12.6 South America Nosocomial Infection Treatment Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Nosocomial Infection Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology